Hepatitis C seropositivity and RNA detection among Type2 Diabetic patients in Sulaimani Governorate-Iraqi Kurdistan Region


Salih A. Hama

Department of Biology/School of Science/University of Sulaimani/KRG

DOI: https://doi.org/10.17656/jzs.10555

Abstract

The current study included 421 cases (221 with type 2 diabetic) and (200 non-diabetics- control group). ELISA and conventional PCR techniques were used for detection of anti-HCV antibodies and HCV-RNA respectively. The percentage rates of HCV seropositivity were (9.5%) among type 2 diabetic patients that were significantly higher (p < 0.05) compared to controls. Moreover, HCV-RNA detection was more frequent among diabetic patients (5.88%), although no significant differences found with non-diabetic cases (p > 0.05). No significant effects of sex found among positive results (p > 0.05). Duration of diabetes, residence, the job type, the patient’s education level, history of jaundice, smoking and alcohol consumption showed significant effects (p < 0.05) on the percentage rates of HCV infection among type 2 diabetic patients. It was concluded that these parameters are a risk factor for HCV infection among Type 2 Diabetic patients. Moreover, diabetes itself can consider as a risk factor for HCV infection.


Key Words:  HCV, Type 2 diabetic, seropositivity, HCV-RNA, anti-HCV antibodies


References:

[1] Feinstone S. M., Kapikian A. Z., Purcell R. H., Alter H. J., Holland P. V. "Transfusion-associated hepatitis is not due to viral hepatitis type A or B", N Engl J Med, Vol 292, pp 767-770. (1975).

[2] Alter H. J., Purcell R. H., Holland P. V., Popper H. "Transmissible agent in non-A, non-B hepatitis" Lancet, Vol. 1, pp 459-­463. (1978).

[3] Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome". Science,Vol. 244, pp 359-362,(1989).

[4] WHO. Weekly epidemiological record: World Health Organization. (1999).

[5] Major M. E., Rehermann B., Feinstone S. M. "Hepatitis C viruses". In Fields Virology, Fourth ed, pp. 1127-1161. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins. (2001).

[6] Clarke A., Kulasegaram R. "Hepatitis C transmission- where are we now?" Int J STD AIDS,Vol.17, pp 74-80,(2006)

[7] Shindo M., Di Bisceglie A. M., Biswas R., Mihalik K., Feinstone S. M. "Hepatitis C virus replication during acute infection in the chimpanzee", J Infect Dis, Vol. 166, pp 424-427. (1992).

[8] Houghton M. "Hepatitis C Viruses". In Fields Virology, 3rd ed, pp. 1035-1058. Edited by D. M. K. B.N. Fields, and P.M. Howley. Philadelphia: Lippincott-Raven Publishers. (1996).

[9] Schlauder G. G., Leverenz G. J., Mattsson L., Weiland O., Mushahwar I. K. "Detection of hepatitis C viral RNA by the polymerase chain reaction in the serum of patients with post-transfusion non-A, non-B hepatitis", J Virol Methods, Vol. 37, pp 89-199. (1992).

[10] Marin M. G., Bresciani S., Puoti M., Rodella A., Gussago A., Ravaggi A., Pizzocolo G., Albertini A., "Mariani E. Clinical Significance of serum hepatitis C virus (HCV) RNA as a marker of HCV infection", J Clin Microbiol, Vol. 32, pp 3008-3012. (1994).

[11] Knobler H., Schattner A. "Associaton of Hepatitis C and Diabetes mellitus", Ann Intern Med. Vol. 132, No.2,pp 141. (2001)

[12] Ryu J. K., Lee S. B., Hong S. J., Lee S. "Association of chronic Hepatitis C virus infection and diabetes mellitus in Korean patients". Korean Journal of Intern Medicine, Vol.16, No.1, pp 18-23. (2001).

[13] Simó R., Hernández C., Genescá J., JardÌ R., Mesa J. "High prevalence of hepatitis C virus infection in diabetic patients", Diabetes Care, Vol.19, pp 998–1000. (1996).

[14] Sangiorgio L., Attardo T., Gangemi R., Rubino C., Barone M., Lunetta M. "Increased frequency of HCV and HBV infection in type 2 diabetic patients", Diabetes Res Clin Pract, Vol. 48, pp 147-51. (2000).

[15] Younas B. B., Khan G. M., Chaudhary M. A. "Prevalence of diabetes mellitus among patients suffering from chronic liver disease", Mother and Child,Vol. 38, No.1, pp 37-40. (2000).

[16] Okan V., Araz M., Aktaran S., Karsligil T., Meram I., Bayraktaroglu Z., Demirci F. "Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey", Int J Clin Prac, Vol. 56, pp 175-7. (2002).

[17] Bahtiyar G., Shin J. J., Aytaman A., Sowers J. R, McFarlane S. I. "Association of diabetes and hepatitis c infection: epidemiologic evidence and pathophysiologic insights", Curr Diab Rep. Vol. 4, No.3, pp 194-198. (2004).

[18] Chen Hua-Fen., Li Chung-Yi., Chen P., See Ting-Ting., Lee Hsin-Yu. "Seroprevalence of Hepatitis B and C in Type 2 Diabetic Patients", J Chin Med Assoc, Vol. l69, No. 4, pp 146-152. (2006).

[19] Ali S. S., Ali I. S., Aamir A. H., Jadoon Z., Inayatullah S. "Frequency of Hepatitis C infection in diabetic patients", Journal of Ayub Med Coll Abbottabad. Vol. 19, No. 1, pp 46-49. (2007).

[20] Nwokediuko S. C., Oli J. M. "Hepatitis C virus infection in Nigerians with Diabetes mellitus". Nigerian Journal of Clinical Practice, Vol. 11, No. 2, pp 94-99. (2008).

[21] Balogun W., Adeleye J., Akinlade K., Otegbayo J. "Low prevalence of hepatitis-C viral seropositivity among patients with type-2 diabetes mellitus in a tertiary hospital", J Natl Med Assoc. Vol. 98, No.11, pp 1805-1808. (2006).

[22] Adegoke O. A., Kolawole B. A., Ikem R. T., Adeniran A., Aboderin A. O., Salawu A. "Seroprevalence of hepatitis C virus infection in Nigerians with Type 2 Diabetes mellitus", Nigerian Journal of Clinical Practice, Vol.11, No.3, pp 199-201. (2008).

[23] Elhawary E. I., Mahmoud G. F., El-Daly M. A., Mekky F. A., Esmat G. G., Abdel-hamid M. "Association of HCV with diabetes mellitus: an Egyptian case-control study", Virology Journal, Vol.8, pp 367. (2011).

[24] Han Ni., Soe Moe., Aung Htet. "Hepatitis C Virus Infection in Diabetes Mellitus Patients", International Journal of Collaborative Research on Internal Medicine & Public Health, Vol. 5, pp 599-606. (2012).

[25] Bhimo T., Laloo D., Prasad L., Ranabir S., Walke P. "Seroprevalence of hepatitis C infection in type 2 diabetes mellitus", Indian Journal of Endocrinology and Metabolism, Vol.19, No.2, pp 296-299. (2015).

[26] Kaabia N., Ben Jazia E., Slim I., Fodha I., Hachfi W., Gaha R., Khalifa M., Hadj A. K., Trabelsi H., Abdelaziz A., Bahri F., Letaief A. "Association of hepatitis C virus infection and diabetes in central Tunisia", World Journal of Gastroenterology, Vol. 15, No.22, pp 2778-2781. (2009).

[27] Cacoub P., Poynard T., Ghillani P., et al. "Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C", Arthritis Rheum, Vol. 42, No.10, pp 2204-12. (1999).

[28] Jadoon N. A., Shahzad M. A., Yaqoob R., Hussain M., Ali N. "Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association", Virology Journal, Vol. 7, pp 304. (2010).

[29] Mehta S. H., et al. "Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States", Ann Intern Med, Vol. 133, No. 8, pp 592-9. (2000).

[30] Olokoba A. B., Badung L. H., Abdulrahman M. B., Salawu F. K., Danburam A., Aderibigbe S., Midala J., Tidi S. K. "Hepatitis C virus infection in Nigerians with diabetes mellitus", American Journal of Science and Industrial Research, Vol. 1, No. 2, pp 135-138. (2010).

[31] Shu-Chun, Chuang, Lee Yuan-Chin Amy, Hashibe Mia, Dai Min, Zheng Tongzhang, Boffetta Paolo. "Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis", Cancer epidemiology, biomarkers & prevention, Vol.19, No.5, pp1261-8. (2010).

[32] Huang Y. W, Wang T. C, Yang S. S, Lin S. Y, Fu S. C, Hu J. T, Liu C. J, Kao J. H, Chen D. S. "Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study", Aliment Pharmacol Ther., Vol. 42, pp 902–911.(2015).

[33] Laloo D; Walke P; Bhima T; Prasad L; Ranabir S. "Seroprevalence of hepatitis C infection in type 2 diabetes mellitus", Indian J Endocrinol Metab. 2015 Mar-Apr, Vol.19, No. 2, pp 296–299. (2015).

[34] Poynard T, Bedossa P, Opolon P. "Natural history of liver fibrosis progression in patients with chronic hepatitis C", The lancet, Vol. 349,(9055)m pp 825–832.(1997)

[35] Roudot-Thoraval F, Bastie A, Pawlotsky J. M, Dhumeaux D. "Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients", The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology. 1997 Aug; Vol. 26, No.2, pp 485-90.(1997).

[36] Oshita M1, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, Katayama K, Fusamoto H, Kamada T. "Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C", Hepatology. Vol. 20, No.5, pp 1115-1120. (1994). [37] Memon M. S, Arain Z. I, Naz F, Zaki M., Kumar S., and Burney A. A. "Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study", Journal of Diabetes Research; Accepted 15 July 2013 [unpublished].